Diabetes
SGLT2 inhibitors improve biomarkers indicative of CVD risk in diabetes patients: Study

… (AIP and TyG indexes), an indicator of cardiovascular risk, in patients with type 2 diabetes, finds a recent study in the journal Minerva Endocrinology.


